Pages that link to "Q33349381"

The following pages link to In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response (Q33349381):

Displaying 49 items.

• HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis (Q24307534) (← links)
• Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis (Q26778403) (← links)
• Sialendoscopic management of autoimmune sialadenitis: a review of literature. (Q33777026) (← links)
• Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease (Q33819490) (← links)
• Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome (Q34473302) (← links)
• Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome (Q34479625) (← links)
• NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome (Q34541173) (← links)
• Association of increased frequencies of HLA-DPB1*05:01 with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese rheumatoid arthritis and systemic lupus erythematosus patients (Q34548358) (← links)
• Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort (Q34743817) (← links)
• Genetic variants are major determinants of CSF antibody levels in multiple sclerosis (Q35533986) (← links)
• Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome (Q35554665) (← links)
• Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome (Q35555698) (← links)
• Lamivudine is not effective in primary Sjögren's syndrome (Q35556009) (← links)
• Horizons in Sjögren's syndrome genetics (Q35570872) (← links)
• Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome (Q35868945) (← links)
• Current Aspects of Pathogenesis in Sjögren's Syndrome (Q36059424) (← links)
• Primary Sjögren's syndrome: current and emergent aetiopathogenic concepts (Q36163155) (← links)
• Reliability of statistical associations between genes and disease (Q36221786) (← links)
• Clinical and pathological roles of Ro/SSA autoantibody system. (Q36469094) (← links)
• The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjogren's syndrome (autoimmune epithelitis). (Q36500399) (← links)
• Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies (Q36570988) (← links)
• Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome (Q36680491) (← links)
• Serologic features of primary Sjögren's syndrome: clinical and prognostic correlation (Q36700816) (← links)
• Sjögren's syndrome: an old tale with a new twist (Q37257149) (← links)
• Olfaction, psychiatric disorders and autoimmunity: is there a common genetic association? (Q37363868) (← links)
• Passively acquired anti-SSA/Ro antibodies are required for congenital heart block following ovodonation but maternal genes are not. (Q37596846) (← links)
• Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome (Q37777643) (← links)
• Sjögren's syndrome in older patients: aetiology, diagnosis and management (Q38076070) (← links)
• Immunopathogenic mechanisms of systemic autoimmune disease (Q38133018) (← links)
• Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca (Q38176265) (← links)
• Association of an IRF5 gene functional polymorphism with Sjögren's syndrome (Q38604875) (← links)
• Genetics of Sjögren's syndrome. (Q39286514) (← links)
• Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling (Q40799131) (← links)
• Clinical Spectrum, Therapeutic Outcomes, and Prognostic Predictors in Sjogren's Syndrome-associated Neuropathy (Q41626218) (← links)
• HLAProfiler utilizes k-mer profiles to improve HLA calling accuracy for rare and common alleles in RNA-seq data. (Q42063952) (← links)
• Epistasis between the MHC and the RCA alpha block in primary Sjögren syndrome (Q42128563) (← links)
• Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis (Q42635006) (← links)
• Atorvastatin inhibits the inflammatory response caused by anti-M(3) peptide IgG in patients with primary Sjögren's syndrome (Q43826601) (← links)
• No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome (Q46525705) (← links)
• Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome (Q47780867) (← links)
• CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients (Q49118975) (← links)
• Sjögren syndrome (Q55970262) (← links)
• A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23 (Q57603213) (← links)
• Molecular Evidence for Precursors of Sjögren's Foci in Histologically Normal Lacrimal Glands (Q60917022) (← links)
• Anti-SSB/La antibody is negatively associated with HLA-DR2 in chronic hepatitis C infection (Q81574905) (← links)
• High-resolution HLA analysis of primary and secondary Sjögren's syndrome: a common immunogenetic background in Mexican patients (Q85643693) (← links)
• Association of HLA Alleles with Primary Sjögren Syndrome in the South Tunisian Population (Q91610724) (← links)
• Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome (Q92286651) (← links)
• Overlapping Sjogren's syndrome reduces the probability of reaching target in rheumatoid arthritis patients: a propensity score matched real-world cohort from 2009 to 2019 (Q94481932) (← links)